NL6700083A - - Google Patents

Info

Publication number
NL6700083A
NL6700083A NL6700083A NL6700083A NL6700083A NL 6700083 A NL6700083 A NL 6700083A NL 6700083 A NL6700083 A NL 6700083A NL 6700083 A NL6700083 A NL 6700083A NL 6700083 A NL6700083 A NL 6700083A
Authority
NL
Netherlands
Application number
NL6700083A
Other versions
NL149493B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6700083A publication Critical patent/NL6700083A/xx
Publication of NL149493B publication Critical patent/NL149493B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL676700083A 1966-01-03 1967-01-03 Werkwijze ter bereiding van een therapeutisch preparaat, gevormd preparaat, alsmede werkwijze ter bereiding van de daarbij toe te passen actieve verbindingen. NL149493B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US517995A US3360518A (en) 1966-01-03 1966-01-03 Tetrahydro-halo-sulfamyl quinazolinones

Publications (2)

Publication Number Publication Date
NL6700083A true NL6700083A (US20100056889A1-20100304-C00004.png) 1967-07-04
NL149493B NL149493B (nl) 1976-05-17

Family

ID=24062092

Family Applications (1)

Application Number Title Priority Date Filing Date
NL676700083A NL149493B (nl) 1966-01-03 1967-01-03 Werkwijze ter bereiding van een therapeutisch preparaat, gevormd preparaat, alsmede werkwijze ter bereiding van de daarbij toe te passen actieve verbindingen.

Country Status (14)

Country Link
US (1) US3360518A (US20100056889A1-20100304-C00004.png)
AT (2) AT286989B (US20100056889A1-20100304-C00004.png)
BE (1) BE692082A (US20100056889A1-20100304-C00004.png)
BR (1) BR6785894D0 (US20100056889A1-20100304-C00004.png)
CH (1) CH515910A (US20100056889A1-20100304-C00004.png)
DE (1) DE1620740C3 (US20100056889A1-20100304-C00004.png)
DK (1) DK134113B (US20100056889A1-20100304-C00004.png)
ES (1) ES334560A1 (US20100056889A1-20100304-C00004.png)
FI (1) FI51350C (US20100056889A1-20100304-C00004.png)
FR (1) FR6844M (US20100056889A1-20100304-C00004.png)
GB (1) GB1170790A (US20100056889A1-20100304-C00004.png)
IL (1) IL27126A (US20100056889A1-20100304-C00004.png)
NL (1) NL149493B (US20100056889A1-20100304-C00004.png)
SE (1) SE390969B (US20100056889A1-20100304-C00004.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458513A (en) * 1967-11-02 1969-07-29 Wallace & Tiernan Inc 2-substituted-tetrahydro-halosulfamyl-quinazolinones
US3452020A (en) * 1967-11-09 1969-06-24 Wallace & Tiernan Inc 2-alkenyl and 2-alkynyl substituted - tetrahydro - halo-sulfamyl-quinazolinones
US3452019A (en) * 1967-11-16 1969-06-24 Wallace & Tiernan Inc 1-phenylalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3518267A (en) * 1968-02-23 1970-06-30 Pennwalt Corp 1-aminoalkyl and 1-hydroxyalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3549629A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2 - substituted or unsubstituted carboxy tetrahydro - halo - sulfamyl-quinazolinones
US3549636A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2-alkanoyl,alkanoylalkyl,alkanoyloxyalkyl,and hydroxyalkyl substituted tetrahydro - halo - sulfamyl- quinazolinones
US3549634A (en) * 1968-03-28 1970-12-22 Pennwalt Corp 8,5 - amino - substituted - tetrahydrohalo-sulfamyl-quinazolinones
US3541096A (en) * 1968-12-24 1970-11-17 Pennwalt Corp 2-aryl-substituted-tetrahydro-halo-sulfamyl-quinazolinones
ZA732937B (en) * 1972-05-05 1974-03-27 Maggioni & C Spa Non mercurial diuretics
EP0057763A1 (en) * 1981-01-26 1982-08-18 Pennwalt Corporation Improved process for the preparation of 2-methyl-3-(o-tolyl)-7-chloro-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
US4522818A (en) * 1982-10-14 1985-06-11 Pennwalt Corporation Diuretic/antihypertensive compositions
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5264439A (en) * 1990-02-13 1993-11-23 Merck & Co., Inc. Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
US5633240A (en) * 1994-09-01 1997-05-27 Academic Pharmaceuticals Parenteral solutions containing metolazone
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
AU1432402A (en) * 2000-11-21 2002-06-03 Sankyo Co Medicinal compositions
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
WO2006055542A2 (en) * 2004-11-15 2006-05-26 Nitromed, Inc. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
EP3025711B1 (en) 2013-07-23 2020-11-18 Daiichi Sankyo Company, Limited Medicine for preventing or treating hypertension
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EA202191892A1 (ru) 2019-01-18 2022-02-24 Астразенека Аб Ингибиторы pcsk9 и способы их применения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) * 1961-03-21 X-tetrahydro -
GB1464445A (en) * 1973-02-19 1977-02-16 Mitsubishi Electric Corp Apparatus for making a printing master
EP0096084B1 (de) * 1982-06-04 1985-10-02 DR.-ING. RUDOLF HELL GmbH Verfahren zur Vermeidung von Bildfehlern beim Mehrfarbendruck, die durch fehlerhaften Übereinanderdruck der Farbauszüge entstehen
GB8410860D0 (en) * 1984-04-27 1984-06-06 Crosfield Electronics Ltd Image modification

Also Published As

Publication number Publication date
CH515910A (de) 1971-11-30
DK134113C (US20100056889A1-20100304-C00004.png) 1977-02-14
IL27126A (en) 1972-01-27
SE390969B (sv) 1977-01-31
DE1620740A1 (de) 1970-05-21
AT291269B (de) 1971-07-12
DK134113B (da) 1976-09-13
BE692082A (US20100056889A1-20100304-C00004.png) 1967-06-16
NL149493B (nl) 1976-05-17
DE1620740C3 (de) 1979-05-10
BR6785894D0 (pt) 1973-12-27
ES334560A1 (es) 1967-11-01
FI51350B (US20100056889A1-20100304-C00004.png) 1976-08-31
US3360518A (en) 1967-12-26
AT286989B (de) 1971-01-11
DE1620740B2 (de) 1978-09-14
GB1170790A (en) 1969-11-19
FR6844M (US20100056889A1-20100304-C00004.png) 1969-04-08
FI51350C (fi) 1976-12-10

Similar Documents

Publication Publication Date Title
DK134113C (US20100056889A1-20100304-C00004.png)
AT281852B (US20100056889A1-20100304-C00004.png)
AU5917865A (US20100056889A1-20100304-C00004.png)
AU428063B2 (US20100056889A1-20100304-C00004.png)
AU424443B2 (US20100056889A1-20100304-C00004.png)
AU421822B2 (US20100056889A1-20100304-C00004.png)
AU415165B1 (US20100056889A1-20100304-C00004.png)
AU414526B2 (US20100056889A1-20100304-C00004.png)
AU433222B2 (US20100056889A1-20100304-C00004.png)
AU417216B2 (US20100056889A1-20100304-C00004.png)
AU6703465A (US20100056889A1-20100304-C00004.png)
AU218666A (US20100056889A1-20100304-C00004.png)
AU5895065A (US20100056889A1-20100304-C00004.png)
AU1144366A (US20100056889A1-20100304-C00004.png)
AU612166A (US20100056889A1-20100304-C00004.png)
AU1111066A (US20100056889A1-20100304-C00004.png)
BE693428A (US20100056889A1-20100304-C00004.png)
BE284991A (US20100056889A1-20100304-C00004.png)
AU414093B2 (US20100056889A1-20100304-C00004.png)
AU411645B2 (US20100056889A1-20100304-C00004.png)
AU407778B2 (US20100056889A1-20100304-C00004.png)
AU2390066A (US20100056889A1-20100304-C00004.png)
BE689045A (US20100056889A1-20100304-C00004.png)
AU1027866A (US20100056889A1-20100304-C00004.png)
AU433620A (US20100056889A1-20100304-C00004.png)

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: PENNWALT

V4 Lapsed because of reaching the maximum lifetime of a patent